Caffeine Doesn't Affect Cardiac Conduction, Refractoriness in SVT

This article originally appeared here.
Share this content:
Caffeine Doesn't Affect Cardiac Conduction, Refractoriness in SVT
Caffeine Doesn't Affect Cardiac Conduction, Refractoriness in SVT

FRIDAY, Jan. 16, 2015 (HealthDay News) -- For patients with symptomatic supraventricular tachycardia (SVT), caffeine is associated with increases in systolic and diastolic blood pressure, but does not impact cardiac conduction or refractoriness, according to a study published in the January issue of the Journal of Cardiovascular Electrophysiology.

Robert Lemery, M.D., from the University of Ottawa Heart Institute in Canada, and colleagues examined the electrophysiological effects of caffeine on atrial and ventricular tissues. Participants included 80 patients with symptomatic SVT undergoing an electrophysiologic study prior to catheter ablation, who were randomized to oral caffeine or placebo.

The researchers found that resting heart rate did not differ significantly between the groups, but caffeine correlated with a significant increase in resting systolic and diastolic blood pressures compared with placebo. There was no significant effect for caffeine on the effective refractory period of the atrium or ventricle, or on atrioventricular node conduction. In all but three patients, SVT was induced, with no significant difference between the groups in SVT inducibility or the cycle length of induced tachycardias.

"Caffeine, at moderate intake, was associated with significant increases in systolic and diastolic blood pressures, but had no evidence of a significant effect on cardiac conduction and refractoriness," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »